Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ISIS > SEC Filings for ISIS > Form 8-K/A on 28-Jun-2013All Recent SEC Filings

Show all filings for ISIS PHARMACEUTICALS INC

Form 8-K/A for ISIS PHARMACEUTICALS INC


28-Jun-2013

Entry into a Material Definitive Agreement, Creation of a Direct Finan


Item 1.01. Entry into a Material Definitive Agreement.

On October 15, 2008, Isis Pharmaceuticals, Inc. ("Isis") and RBS Asset Finance, Inc. ("RBS") originally entered into a Loan Agreement related to an equipment financing. On June 27, 2012 Isis and RBS amended the Loan Agreement to extend the time Isis has to draw funding under the agreement through April 15, 2014 and increase the maximum amount in principal Isis may borrow to finance the purchase of equipment to $33.4 million (such agreement, as amended, the "Loan Agreement").

On June 27, 2013, Isis drew approximately $2.5 million in additional principal under the Loan Agreement, bringing the total amount of principal borrowed by Isis under the Loan Agreement to $29.9 million.

Each new loan under the Loan Agreement will have a term of approximately 3 years, with principal and interest payable monthly. Interest on amounts Isis borrows under the Loan Agreement will be calculated based upon the 3 year interest rate swap at the time of each loan plus 3.5%. As collateral, RBS will have a security interest in the equipment purchased under the Loan Agreement.

Under the Loan Agreement, each of the following events is an event of default, which may result in acceleration of the amounts payable under the Loan Agreement:

Isis fails to timely pay amounts due under the Loan Agreement;

Isis fails to perform or observe its material obligations under the Loan Agreement or another agreement with RBS, and such failure continues after a reasonable notice and cure period;

Isis defaults under any of its other debt having a principal amount in excess of $10 million;

Isis fails to pay a judgment or order to pay money that is excess of $10 million, unless covered by Isis' insurance or under appeal by Isis;

The occurrence of a change of control of Isis, where the acquiring entity does not satisfy specified minimum credit criteria; or

Isis becomes insolvent or enters bankruptcy proceedings.



Item 2.03. Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.

Reference is made to the disclosures set forth in Item 1.01 above, and are incorporated herein by reference.

In this report, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals.


* * *

  Add ISIS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ISIS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.